Targeting AMPK by Statins: A Potential Therapeutic Approach
Sajad Dehnavi(Ahvaz Jundishapur University of Medical Sciences), Amirhossein Sahebkar(Mashhad University of Medical Sciences), Tannaz Jamialahmadi(Mashhad University of Medical Sciences), Stephen L. Atkin(Royal College of Surgeons in Ireland - Bahrain), Amirhossein Kiani(Ahvaz Jundishapur University of Medical Sciences), Ali Farhadi Biregani(Ahvaz Jundishapur University of Medical Sciences), Mahvash Sadeghi(Ahvaz Jundishapur University of Medical Sciences), Maciej Banach(John Paul II Catholic University of Lublin)
Cited by 100
Related Papers
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|674
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
|Journal of the American Heart Association|2019|431
Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
|Archives of Medical Science|2015|383